Maria Krutikov

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

Madhumita Shrotri, Maria Krutikov, Tom Palmer et al. · The Lancet Infectious Diseases · 2021 · 193 citations · Full text

Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey

Laura Shallcross, Danielle Burke, Owen Abbott et al. · The Lancet Healthy Longevity · 2021 · 139 citations · Full text

Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England

Maria Krutikov, Tom Palmer, Gokhan Tut et al. · The Lancet Healthy Longevity · 2021 · 127 citations · Full text

Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study

Maria Krutikov, Tom Palmer, Gokhan Tut et al. · The Lancet Healthy Longevity · 2021 · 71 citations · Full text

Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study

Gokhan Tut, Tara Lancaster, Maria Krutikov et al. · The Lancet Healthy Longevity · 2021 · 51 citations · Full text